Bringing together world-class healthcare leaders, entrepreneurs, technology firms, policy makers, financiers and forward thinkers, the second annual d.health Summit will discuss and foster the adoption of technology-enabled solutions to improve the health of Aging Americans. By focusing on high engagement and networking, attendees will learn, share and evaluate transformative approaches, as well as create new partnerships to improve care and generate economic value for one of the country’s largest industries, in one of its most vibrant cities.
NewYorkBIO supports the development and growth of New York State's life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development.
26 of NYC's most talented academic entrepreneurs will showcase their work to venture capitalists, angel investors and biopharma business development executives at the Alexandria Center for Life Science. Please join us for an exciting day of rapid-fire business pitches, roundtable discussions, distinguished keynote speakers, and networking with biomedical and scientific innovators from New York City's world-class academic research centers.
Thong Q. Le serves as Chief Executive Officer (CEO) of Accelerator Corporation. With more than 16 years of experience in identifying, investing, managing, and successfully exiting numerous seed and early-stage investments, Mr. Le is positioned to grow and expand the Accelerator investment model. He currently serves as CEO and Director of Acylin Therapeutics and Oncofactor Corporation, and is a Board Observer at Cardeas Pharma, and Qazzow.
Prior to becoming CEO at Accelerator, Mr. Le served as a Managing Director at WRF Capital, the venture capital investment arm of Washington Research Foundation in Seattle, WA. During his 13-year tenure at WRF Capital, Mr. Le played a significant role in the early sourcing, financing, and development of numerous start-up companies, including Alder Biopharmaceuticals (NASDAQ: ALDR), Corus Pharma (acquired by Gilead Sciences), Halosource (LSE: HALO.L), Hyperion Therapeutics (Nasdaq: HPTX), Lumera (NasdaqNM:LMRA), Performant (acquired by Mercury Interactive), Pathway Medical Technologies (acquired by MEDRAD, Inc.), and VLST (asset acquisition by major international pharmaceutical company). He also led WRF Capital’s investments in Accelerator, ARZEDA, AppAttach, Cardeas Pharma, Qazzow, Resolve Therapeutics, and Uptake Medical, all companies where he was actively involved in establishing as a founding or early investor.
Prior to joining WRF Capital, Mr. Le was the founder, president and CEO of MiniMeals, Inc. and a consultant for Capital Management Consulting, Inc. Earlier, he was at Raymond James & Associates, Singer & Xenos Investment Management Company and Capital Management Group LLC, a private investment firm specializing in biomedical ventures.
Mr. Le completed post-graduate studies at the Templeton College of Oxford University and earned a bachelor of arts cum laude in government from Harvard University. He currently serves on the executive boards of the Evergreen Venture Capital Association (EVCA), the Washington Biotechnology & Biomedical Association (Chairman), and the Washington Global Health Fund. He was previously named one of the region’s "40 Under 40” by the Puget Sound Business Journal.
NewYorkBIO Members: $65
Future Members: $95
New York Harbor World Yacht at Pier 81, Manhattan
4:30 p.m. Boarding
5:00 p.m. Cocktails and Dinner
9:00 p.m. Disembark
Please join us as the harbor lights shine on the NJ/NY biotech community on our 2016 NewX2 BioCruise!